Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • After losing Fortis...

    After losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 crore

    Written by Ruby Khatun Khatun Published On 2018-08-06T17:22:10+05:30  |  Updated On 6 Aug 2018 5:22 PM IST
    After losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 crore

    Mumbai: After losing the battle from IHH healthcare for Fortis Healthcare, Manipal Hospitals is now vying for AMRI Hospitals Ltd (Advanced Medical Research Institute) in Kolkata.


    ET recently reported that Manipal Hospitals has revived talks with FMCG major Emami Group to acquire its AMRI Hospitals Ltd. Emami is looking for a valuation of Rs 800-1,000 crore for the hospital chain.


    In AMRI, Emami holds about 98 percent stake while the remaining 2 percent is held by West Bengal government. AMRI Hospitals has about 1,000 beds under five hospitals, four in Kolkata and one in Bhubaneswar.


    An Emami spokesperson told ET that the group does not have any plans to sell its hospital business.


    Over the past few years, AMRI has been in the news for all the wrong reasons. In 2011, a major fire broke out in AMRI Hospital in Dhakuria in which 93 peoples were dead and these led the promoters to face a major setback and the directors are facing trial for culpable homicide leaving the hospital shut for two years.


    In 2013, the Supreme Court ordered AMRI Hospitals and three of its doctors to pay Rs 5.96 crore along with interest as compensation to a non-resident Indian doctor in a case of medical negligence.


    In 2014, S K Todi-led Shrachi Group sold its 32% stake in AMRI Hospitals to Emami after the mounting losses.


    It has been reported that Manipal Hospitals is also eyeing Hyderabad based hospital chain Star Hospitals.


    Read also: IHH Healthcare: Meet the Highest Bidder of Fortis Healthcare


    The due diligence process is currently on valuing the Hyderabad-headquartered healthcare services provider at about Rs 500 crore reports ET.


    Emami was founded by RS Agarwal and RS Goenka families in 1974 and entered healthcare sector in 1999 by joining hands with Shrawan Kumar Todi of Shrachi Group, a Kolkata-based real estate developer.

    acquireAdvanced Medical Research InstituteAMRIAMRI HospitalsAMRI Hospitals LtdAvendus CapitalBhubaneswarbuyculpable homicideDhakuriaEmamiEmami GroupFMCGFortis HealthcaregovernmentIHH Healthcareinvestment bankKolkataManipalManipal Hospitalsmedical negligenceRS AgarwalRS GoenkaS K TodiShrachi GroupShrawan Kumar TodiStar HospitalsSupreme CourtWest Bengal
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok